M 41
Pill imprint M 41 has been identified as Spironolactone and hydrochlorothiazide 25 mg / 25 mg.
Hydrochlorothiazide/spironolactone is used in the treatment of edema; nephrotic syndrome; high blood pressure; ascites; heart failure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy.
Hydrochlorothiazide/spironolactone 25 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Spironolactone and hydrochlorothiazide Images
- Imprint:
-
M 41
- Strength:
- 25 mg / 25 mg
- Color:
- Beige
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
lactose
magnesium stearate
microcrystalline cellulose
menthol
peppermint oil
sodium lauryl sulfate
sodium starch glycolate
starch
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0141
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0104 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More Spironolactone and Hydrochlorothiazide resources
- Hydrochlorothiazide/Spironolactone (Wolters Kluwer)
- Spironolactone/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and spironolactone (Cerner Multum)
- spironolactone and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Spironolactone and Hydrochlorothiazide (FDA)
- Spironolactone/Hydrochlorothiazide (Wolters Kluwer)


